Cargando…
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s
BACKGROUND: The molecular drivers of early sporadic Parkinson’s disease (PD) remain unclear, and the presence of widespread end stage pathology in late disease masks the distinction between primary or causal disease-specific events and late secondary consequences in stressed or dying cells. However,...
Autores principales: | Toomey, Christina E., Heywood, Wendy E., Evans, James R., Lachica, Joanne, Pressey, Sarah N., Foti, Sandrine C., Al Shahrani, Mesfer, D’Sa, Karishma, Hargreaves, Iain P., Heales, Simon, Orford, Michael, Troakes, Claire, Attems, Johannes, Gelpi, Ellen, Palkovits, Miklos, Lashley, Tammaryn, Gentleman, Steve M., Revesz, Tamas, Mills, Kevin, Gandhi, Sonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461181/ https://www.ncbi.nlm.nih.gov/pubmed/36076304 http://dx.doi.org/10.1186/s40478-022-01424-6 |
Ejemplares similares
-
Oxidative Stress: Mechanistic Insights into Inherited Mitochondrial Disorders and Parkinson’s Disease
por: Al Shahrani, Mesfer, et al.
Publicado: (2017) -
Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer’s disease
por: Toomey, Christina E., et al.
Publicado: (2020) -
White matter DNA methylation profiling reveals deregulation of HIP1, LMAN2, MOBP, and other loci in multiple system atrophy
por: Bettencourt, Conceição, et al.
Publicado: (2019) -
Alterations in global DNA methylation and hydroxymethylation are not detected in Alzheimer's disease
por: Lashley, Tammaryn, et al.
Publicado: (2015) -
Heterogeneous Nuclear Ribonucleoproteins: Implications in Neurological Diseases
por: Low, Yi-Hua, et al.
Publicado: (2020)